The super generics industry analysis in europe for US$ 11.6 billion in 2023 and are predicted to grow to US$ 14.2 billion by 2033. Over the projected period from 2023 to 2033, it is predicted to grow at a CAGR of nearly 2.0%. In terms of value share, the anti-diabetic segment held 13.3%, and in …